Valeant Pharmaceuticals Intl Inc Stock Is Worth the Risk

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has begun a turnaround.The Laval, Canada-based drug manufacturer is on a growth path again after VRX stock came crashing from lofty highs.A new CEO now works to drive profits and reduce a heavy debt burden.